Le Du F, Eckhardt BL, Lim B, Litton JK, Moulder S, Meric-Bernstam F, et al
[DOI] [PubMed] [Google Scholar] 203.Shoshan-Barmatz V, De Pinto V, Zweckstetter M, Raviv Z, Keinan N, Arbel N
Purified proteasome (no IDE) was treated with increasing concentrations of NO donor and assessed for chymotrypsin-like activity using a fluorogenic proteasome substrate
According to NICE guideline NG88, management depends on symptom severity, fibroid characteristics, and the woman's desire for future fertility, ranging from watchful waiting for asymptomatic cases to medical treatments (such as hormonal therapies) or surgical interventions including myomectomy or hysterectomy for severe cases
95% CI, 0.62-0.84
10.1002/oby.21939 35 MitchellJ